Lo T C, Seckel B R, Salzman F A, Wright K A
Department of Radiation Oncology, Lahey Clinic Medical Center, Burlington, MA 01805.
Radiother Oncol. 1990 Nov;19(3):267-72. doi: 10.1016/0167-8140(90)90153-n.
Low megavolt electron beam irradiation was used on 354 sites in 199 patients at the Lahey Clinic either for palliation of symptomatic hypertrophic scars or as post-operative irradiation in an attempt to prevent formation or recurrence of hypertrophic scars. Electron energies used ranged from 1.5 to 3.5 MeV. The median age of the 59 male patients was 22 years and of the 140 female patients, 35 years. All patients had at least one follow-up visit, and the median follow-up was 35 months. Of the 294 sites treated for the first time, 272 (93%) were irradiated with a single fraction with a skin dose ranging from 2 to 20 Gy. Of the 85 sites in 63 patients without excision of symptomatic hypertrophic scars, single-dose electron beam irradiation was of clinically significant value in only 41 sites (48%). No patients have been treated without surgical excision since 1973. Because of a history of formation of hypertrophic scars elsewhere in the body, 13 patients with 19 incisions were treated prophylactically after operation for other diseases. All sites were irradiated with single doses ranging from 8 to 20 Gy, and hypertrophic scars did not subsequently develop in any patient. Altogether, 119 patients with 174 sites were irradiated after surgical excision of hypertrophic scars to prevent recurrence; 168 sites (97%) received single-fraction irradiation, and 161 received a dose of 8 Gy or greater, up to 15 Gy. No statistically significant differences were observed in complete success rates, ranging from 82 to 90% with doses of 9 Gy or greater.(ABSTRACT TRUNCATED AT 250 WORDS)
在拉希诊所,对199例患者的354个部位进行了低兆伏电子束照射,用于缓解有症状的增生性瘢痕,或作为术后照射,以试图预防增生性瘢痕的形成或复发。使用的电子能量范围为1.5至3.5兆电子伏特。59例男性患者的中位年龄为22岁,140例女性患者的中位年龄为35岁。所有患者至少进行了一次随访,中位随访时间为35个月。在首次治疗的294个部位中,272个(93%)接受了单次照射,皮肤剂量范围为2至20戈瑞。在63例未切除有症状增生性瘢痕的患者的85个部位中,单剂量电子束照射仅在41个部位(48%)具有临床显著价值。自1973年以来,没有患者未经手术切除就接受治疗。由于身体其他部位有增生性瘢痕形成史,13例有19处切口的患者在因其他疾病手术后接受了预防性治疗。所有部位均接受了8至20戈瑞的单次剂量照射,随后没有任何患者出现增生性瘢痕。总共,119例患者的174个部位在增生性瘢痕手术切除后接受了照射以预防复发;168个部位(97%)接受了单次照射,161个部位接受了8戈瑞或更高剂量,最高达15戈瑞。在9戈瑞或更高剂量下,完全成功率在82%至90%之间,未观察到统计学上的显著差异。(摘要截断于250字)